These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 20628262)

  • 1. Hypothesis: kisspeptin mediates male hypogonadism in obesity and type 2 diabetes.
    George JT; Millar RP; Anderson RA
    Neuroendocrinology; 2010; 91(4):302-7. PubMed ID: 20628262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why kisspeptin is such important for reproduction?
    Meczekalski B; Podfigurna-Stopa A; Genazzani AR
    Gynecol Endocrinol; 2011 Jan; 27(1):8-13. PubMed ID: 20672907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kisspeptin signalling in the brain: steroid regulation in the rodent and ewe.
    Smith JT
    Brain Res Rev; 2008 Mar; 57(2):288-98. PubMed ID: 17509691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the neuroendocrine reproductive axis by kisspeptin-GPR54 signaling.
    Smith JT; Clifton DK; Steiner RA
    Reproduction; 2006 Apr; 131(4):623-30. PubMed ID: 16595713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of leptin receptor and kisspeptin/GPR54 in the murine hypothalamus contributes to male hypogonadism caused by high-fat diet-induced obesity.
    Zhai L; Zhao J; Zhu Y; Liu Q; Niu W; Liu C; Wang Y
    Endocrine; 2018 Oct; 62(1):195-206. PubMed ID: 29948931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GnRH receptor and GPR54 inactivation in isolated gonadotropic deficiency.
    de Roux N
    Best Pract Res Clin Endocrinol Metab; 2006 Dec; 20(4):515-28. PubMed ID: 17161329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RF9: May it be a new therapeutic option for hypogonadotropic hypogonadism?
    Sahin Z; Kelestimur H
    Med Hypotheses; 2019 Jul; 128():54-57. PubMed ID: 31203909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The kisspeptin system of the human hypothalamus: sexual dimorphism and relationship with gonadotropin-releasing hormone and neurokinin B neurons.
    Hrabovszky E; Ciofi P; Vida B; Horvath MC; Keller E; Caraty A; Bloom SR; Ghatei MA; Dhillo WS; Liposits Z; Kallo I
    Eur J Neurosci; 2010 Jun; 31(11):1984-98. PubMed ID: 20529119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kisspepeptin-GPR54 signaling in the neuroendocrine reproductive axis.
    Gottsch ML; Clifton DK; Steiner RA
    Mol Cell Endocrinol; 2006 Jul; 254-255():91-6. PubMed ID: 16762492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The roles of kisspeptins and G protein-coupled receptor-54 in pubertal development.
    Tena-Sempere M
    Curr Opin Pediatr; 2006 Aug; 18(4):442-7. PubMed ID: 16915001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the pathophysiology of hypogonadism in men with type 2 diabetes: kisspeptin-10 stimulates serum testosterone and LH secretion in men with type 2 diabetes and mild biochemical hypogonadism.
    George JT; Veldhuis JD; Tena-Sempere M; Millar RP; Anderson RA
    Clin Endocrinol (Oxf); 2013 Jul; 79(1):100-4. PubMed ID: 23153270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GPR54 and kisspeptin in reproduction.
    Tena-Sempere M
    Hum Reprod Update; 2006; 12(5):631-9. PubMed ID: 16731583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oestrogen, kisspeptin, GPR54 and the pre-ovulatory luteinising hormone surge.
    Clarkson J; Herbison AE
    J Neuroendocrinol; 2009 Mar; 21(4):305-11. PubMed ID: 19207812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivating KISS1 mutation and hypogonadotropic hypogonadism.
    Topaloglu AK; Tello JA; Kotan LD; Ozbek MN; Yilmaz MB; Erdogan S; Gurbuz F; Temiz F; Millar RP; Yuksel B
    N Engl J Med; 2012 Feb; 366(7):629-35. PubMed ID: 22335740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypogonadotropic hypogonadism in men with type 2 diabetes.
    Dandona P; Dhindsa S; Chandel A; Chaudhuri A
    Postgrad Med; 2009 May; 121(3):45-51. PubMed ID: 19491539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kisspeptin/GPR54 system as potential target for endocrine disruption of reproductive development and function.
    Tena-Sempere M
    Int J Androl; 2010 Apr; 33(2):360-8. PubMed ID: 19906185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of gonadotropin releasing hormone in normal and pathologic endocrine processes.
    Rothman MS; Wierman ME
    Curr Opin Endocrinol Diabetes Obes; 2007 Aug; 14(4):306-10. PubMed ID: 17940457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of hypothyroidism and endocrine disruptor-dependent non-thyroidal illness syndrome on the GnRH-gonadotroph axis of the adult male rat.
    Toni R; Della Casa C; Castorina S; Cocchi D; Celotti F
    J Endocrinol Invest; 2005; 28(11 Suppl Proceedings):20-7. PubMed ID: 16760620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurobiological mechanisms underlying kisspeptin activation of gonadotropin-releasing hormone (GnRH) neurons at puberty.
    Clarkson J; Han SK; Liu X; Lee K; Herbison AE
    Mol Cell Endocrinol; 2010 Aug; 324(1-2):45-50. PubMed ID: 20109523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypogonadotrophic hypogonadism in type 2 diabetes.
    Dandona P; Dhindsa S; Chaudhuri A; Bhatia V; Topiwala S
    Aging Male; 2008 Sep; 11(3):107-17. PubMed ID: 18821286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.